| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/14/2002 | WO2001069200A3 Methods for detection of differences in nucleic acids |
| 03/14/2002 | WO2001068836A3 Methods and compositions for rna interference |
| 03/14/2002 | WO2001064920A3 Hybrid expression of neisserial proteins |
| 03/14/2002 | WO2001063286A3 Method for antigen-specific stimulation of t-lymphocytes with synthetic peptide libraries |
| 03/14/2002 | WO2001063245A3 Method and apparatus for high throughput cell - based assays for screening and diagnostics |
| 03/14/2002 | WO2001062969A3 Estrogen receptor alpha variants and methods of detection thereof |
| 03/14/2002 | WO2001062964A3 A genetic determinant for malignant melanoma |
| 03/14/2002 | WO2001062377A3 Microarray fabrication techniques and apparatus |
| 03/14/2002 | WO2001061007A3 Fibroblast growth factor-23 molecules and uses thereof |
| 03/14/2002 | WO2001059129A3 Mammalian secreted group iii phospholipase a2 |
| 03/14/2002 | WO2001059064A3 Nucleic acids, proteins, and antibodies |
| 03/14/2002 | WO2001057250A3 Method for determining a predisposition of pigs to boar taint |
| 03/14/2002 | WO2001057239A3 Reagent test strip for analyte determination |
| 03/14/2002 | WO2001057085A3 G-protein coupled receptors |
| 03/14/2002 | WO2001055410A3 Ceramidase compositions and methods based thereon |
| 03/14/2002 | WO2001055392A3 Nuclear hormone receptors |
| 03/14/2002 | WO2001055358A3 Phosphodiesterases |
| 03/14/2002 | WO2001055312A3 Nucleic acids, proteins, and antibodies |
| 03/14/2002 | WO2001054707A3 Modification of surface proteins by aminopeptidase inhibitors |
| 03/14/2002 | WO2001053516A3 Detection system for verifying the originality of an object and a test device for carrying out said verification |
| 03/14/2002 | WO2001051919A9 High-throughput formation, identification, and analysis of diverse solid-forms |
| 03/14/2002 | WO2001051660A3 Method and kit for diagnosis of neoplastic transformation |
| 03/14/2002 | WO2001051519A3 Potassium channel mutants of the saccharomyces cerevisiae yeast and the use thereof for the screening of eukaryotic potassium channels |
| 03/14/2002 | WO2001045755A3 Method and applicator for detecting cleaning and/or disinfection of surfaces or objects |
| 03/14/2002 | WO2001044497A3 Protein kinase regulation |
| 03/14/2002 | WO2001042508A3 Methods and compositions relating to electrical detection of nucleic acid reactions |
| 03/14/2002 | WO2001038581A3 Vigilance nucleic acids and related diagnostic, screening and therapeutic methods |
| 03/14/2002 | WO2001036684A3 Mammalian toxicological response markers |
| 03/14/2002 | WO2001034836A3 Susceptibility locus for osteoarthritis |
| 03/14/2002 | WO2001027267A3 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 03/14/2002 | WO2001023572A3 Polynucleotides and polypeptides encoded thereby |
| 03/14/2002 | WO2001020031A3 Polymorphisms in a klotho gene |
| 03/14/2002 | WO2001016364A3 Methods of diagnosing or prognosticating age-related macular degeneration |
| 03/14/2002 | WO2000063441A3 Single nucleotide polymorphisms in mitochondrial genes that segregate with alzheimer's disease |
| 03/14/2002 | WO2000058483A9 Protozoan expression system |
| 03/14/2002 | WO2000056927A3 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
| 03/14/2002 | WO2000056921A3 Nucleic acid combination |
| 03/14/2002 | WO2000056899A9 Dsp-2 dual-specificity map kinase phosphatase |
| 03/14/2002 | WO2000055335A9 Pseudotyped lentiviral vectors and uses thereof |
| 03/14/2002 | WO2000053742A9 Polynucleotides and proteins encoded thereby |
| 03/14/2002 | WO2000049557A9 Computer-implemented nucleic acid isolation method and apparatus |
| 03/14/2002 | US20020032915 Detecting size defect in animal infants; obtain tissue biopsy, monitor expression of somatomedins in sample, amplified somatomedin concentration indicates potential size defect in animals |
| 03/14/2002 | US20020032913 Gene Search Vector and Gene Search Method |
| 03/14/2002 | US20020032912 Detecting modulators of transcriotional activity; obtain genetically engineered cells, expose to modulators, evaluate reporter gene expression |
| 03/14/2002 | US20020032323 Polynucleotide and polypeptide sequence information stored on computer readable media |
| 03/14/2002 | US20020032319 Human single nucleotide polymorphisms |
| 03/14/2002 | US20020031831 Plasmid for use in vaccination and gene therapy |
| 03/14/2002 | US20020031819 Screening process for antibacterial agents |
| 03/14/2002 | US20020031816 Method of inhibition of human glycogen phosphorylase |
| 03/14/2002 | US20020031800 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | US20020031797 Novel nucleic acid isolated from tetrahymena which codes for a triterpenoid cyclase, its production, and use |
| 03/14/2002 | US20020031796 Using enzyme mixture |
| 03/14/2002 | US20020031795 Calibration using fluorescence signals |
| 03/14/2002 | US20020031794 Using nucleotide diphosphate or triphosphate |
| 03/14/2002 | US20020031792 Complexing with monoclonal antibodies |
| 03/14/2002 | US20020031790 Reducing inaccuracy in protein activity; obtain target particles, incubate with probes, monitor and detect binding activity of particles |
| 03/14/2002 | US20020031778 Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acids |
| 03/14/2002 | US20020031777 Ultra yield amplification reaction |
| 03/14/2002 | US20020031776 Amplification; chain extension |
| 03/14/2002 | US20020031775 Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes |
| 03/14/2002 | US20020031774 Process for aligning macromolecules by passage of a meniscus and applications |
| 03/14/2002 | US20020031772 Method of detecting nucleic acid |
| 03/14/2002 | US20020031771 Nucleic acid profile of preferential sample; obtain nucleotide sequences from sample, sequence, compare sequence with those in sequence libraries, detect homology |
| 03/14/2002 | US20020031770 Method for assaying clustered DNA damages |
| 03/14/2002 | US20020031769 Processes for detecting polynucleotides, determining genetic mutations or defects in genetic material, separating or isolating nucleic acid of interest from samples, and useful compositions of matter and multi-hybrid complex compositions |
| 03/14/2002 | US20020031768 Method for quantitative analysis of a nucleic acid amplification reaction |
| 03/14/2002 | US20020031767 Diagnosing inflammatory bowel disease; obtain sample, detect preferential gene expression, the presence of preferential gene expression indicates inflammatory bowel disease |
| 03/14/2002 | US20020031766 Designing preferential particles; provide target, mix with ligands, form microarrays, bind target to preferential particle |
| 03/14/2002 | US20020031765 Oligonucleotides for identifying precursors of amidated polypeptide hormones |
| 03/14/2002 | US20020031764 Generating preferential nucleotide sequences; obtain nucleic acid mix, incubate with polymerase, amplify sequences, recover preferential sequences |
| 03/14/2002 | US20020031761 Amino acid sequences for use in the detection and separation of preferential microorganism from samples |
| 03/14/2002 | US20020031760 Nucleotide sequences for use in the detection of preferential microorganism |
| 03/14/2002 | US20020031759 Diagnosing pancreatic defect in humans; obtain organelle sample, detect preferential organelle, monitor sample for organelle defect, diagnose pancreatic defect |
| 03/14/2002 | US20020031496 Therapy for cellular accumulation in chronic inflammatory diseases |
| 03/14/2002 | US20020031492 Providing a brain tumor sample, quantifying the expression of an interleukin-13 (IL-13) receptor in the sample; and correlating the quantity of expression of the IL-13 receptor with the tumor type or grade; prognosis |
| 03/14/2002 | US20020031255 Multi-neural net imaging apparatus and method |
| 03/14/2002 | US20020029969 Substrate with many channels filled with a homogeneous separation matrix which acts as an obstacle to the electrophoretic migration of the charged molecules, using a series of micro-electrodes to move a sample |
| 03/14/2002 | US20020029964 Electrochemical sensor |
| 03/14/2002 | US20020029814 Microfabricated elastomeric valve and pump systems |
| 03/14/2002 | DE10043845A1 Verfahren zur Messung der Aktivität der NO-Synthase A method for measuring the activity of NO synthase |
| 03/14/2002 | DE10043591A1 Verfahren zur Erfassung von Resistenz-Profilen von Geweben und Zellinien A method for detecting resistance profiles of tissues and cell lines |
| 03/14/2002 | DE10043227A1 Neuartiges entwicklungsbiologisches Gen Novel biological developmental gene |
| 03/14/2002 | DE10042827A1 Dimerization cofactor of homeodomain proteins as tumor marker, useful for in vitro diagnosis of melanoma |
| 03/14/2002 | DE10042177A1 New acetylcholine receptor subunit, useful for identifying plant-protection and therapeutic agents, comprises segment of insect subunit inserted into vertebrate subunit |
| 03/14/2002 | DE10041515A1 Verfahren zur Herstellung gebrauchsfertiger, Antigen-beladener oder -unbeladener, kryokonservierter reifer dendritischer Zellen Process for the production of ready, antigen-loaded or -unbeladener, cryopreserved mature dendritic cells |
| 03/14/2002 | DE10041411A1 Screeningverfahren zur Findung von die Endocytose fördernden Hilfsstoffen Screening method for discovering the endocytosis promoting adjuvants |
| 03/14/2002 | CA2835978A1 Amplification of hiv-1 sequences for detection of sequences associated with drug-resistance mutations |
| 03/14/2002 | CA2731495A1 Amplification of hiv-1 sequences for detection of sequences associated with drug-resistance mutations |
| 03/14/2002 | CA2423247A1 Gene markers useful for detecting skin damage in response to ultraviolet radiation |
| 03/14/2002 | CA2422202A1 Modified carbon, silicon and germanium surfaces |
| 03/14/2002 | CA2422114A1 Novel human cancer/testis antigen and gene thereof |
| 03/14/2002 | CA2421922A1 Proteases |
| 03/14/2002 | CA2421912A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | CA2421872A1 Mechanism of mitochondrial membrane permeabilization by hiv-1 vpr, mimetics of vpr and methods of screening active molecules having the ability to alter and/or prevent and/or mimic the interaction of vpr with ant |
| 03/14/2002 | CA2421858A1 Reporter system for cell surface receptor-ligand binding |
| 03/14/2002 | CA2421857A1 Method |
| 03/14/2002 | CA2421834A1 Use of carp inhibitors for the treatment of heart diseases |
| 03/14/2002 | CA2421783A1 Receptor in the edb fibronectin domain |
| 03/14/2002 | CA2421760A1 G-csf analog compositions and methods |
| 03/14/2002 | CA2421757A1 G-csf analog compositions and methods |